AnaptysBio Inc — Quarterly Financial Statistics (NASDAQ:ANAB) | MetaTrader

Open full chart

Financials

Overview Finanzbericht Statistics Dividends

Quarterly Annual

Cash from operating activities 10.09 M66.67 M10.7 M40.24 M27.36 M 144.97 M Cash from investing activities 58.62 M-29.4 M14.85 M36.4 M103.28 M 125.14 M Cash from financing activities 71.23 M27.57 M28.59 M50.5 M10.39 M 117.05 M Free cash flow 10.05 M66.41 M10.66 M40.2 M27.34 M 144.62 M

Nachrichten

FDA akzeptiert Zulassungsantrag von Vanda für Medikament gegen seltene Hautkrankheit

FDA accepts Vanda’s imsidolimab application for rare skin disorder

AnaptysBio-Aktie erreicht 52-Wochen-Hoch bei 57,73 $

AnaptysBio stock hits 52-week high at $57.73

These IBD 50 Stocks Form Secondary Buy Areas, But Watch These Risks

AnaptysBio-Aktie erreicht 52-Wochen-Hoch von 52,56 $

AnaptysBio stock hits 52-week high at $52.56

Biotech Leader Eyes Spinoff Amid Massive Sales Surge

AnaptysBio: Direktorin verkauft Aktien im Wert von über 530.000 US-Dollar

AnaptysBio, Inc. (ANAB) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

AnaptysBio-Aktie: UBS bestätigt Kaufempfehlung trotz Rechtsstreit mit GSK/n

AnaptysBio stock: UBS reiterates Buy rating amid ongoing GSK litigation